Healthcare provider profile · identity verified

Glenn B Burt, MD

Family Practice · WAUSAU, WI · NPI 1891796553

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	188	60
Gabapentin	Gabapentin	131	24
Lisinopril	Lisinopril	124	42
Metoprolol Succinate	Metoprolol Succinate	118	37
Omeprazole	Omeprazole	106	29
Albuterol Sulfate Hfa	Albuterol Sulfate	101	32
Levothyroxine Sodium	Levothyroxine Sodium	83	24
Amlodipine Besylate	Amlodipine Besylate	76	27
Furosemide	Furosemide	74	24
Metformin Hcl	Metformin Hcl	70	19
Duloxetine Hcl	Duloxetine Hcl	68	suppressed
Eliquis	Apixaban	66	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	suppressed
Losartan Potassium	Losartan Potassium	56	17
Tamsulosin Hcl	Tamsulosin Hcl	50	17
Simvastatin	Simvastatin	48	14
Hydrochlorothiazide	Hydrochlorothiazide	47	11
Allopurinol	Allopurinol	45	11
Sertraline Hcl	Sertraline Hcl	45	13
Pantoprazole Sodium	Pantoprazole Sodium	38	suppressed
Jardiance	Empagliflozin	36	suppressed
Potassium Chloride	Potassium Chloride	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Cephalexin	Cephalexin	32	24
Donepezil Hcl	Donepezil Hcl	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Ibuprofen	Ibuprofen	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Prednisone	Prednisone	29	14
Montelukast Sodium	Montelukast Sodium	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Pregabalin	Pregabalin	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Famotidine	Famotidine	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	16
Tramadol Hcl	Tramadol Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Meloxicam	Meloxicam	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Diazepam	Diazepam	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Glimepiride	Glimepiride	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nyamyc	Nystatin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Motegrity	Prucalopride Succinate	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Flunisolide	Flunisolide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error